Renin‐angiotensin system inhibitors for treating COVID‐19 in adults

ABSTRACT

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows Primary Objective To evaluate the effects of renin‐angiotensin system (RAS) inhibitors in the treatment of adult patients with COVID‐19 on total serious adverse events (TSAEs) at any stage of the illness. Secondary Objectives To evaluate the effects of RAS inhibitors in the treatment of adult patients with COVID‐19 on hospitalization duration and invasive mechanical ventilation duration.